HOME >> MEDICINE >> NEWS
Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy

(PHILADELPHIA) -- The number of tumor cells circulating in the bloodstream of patients with metastatic, hormone-resistant, prostate cancer can predict how they will do with chemotherapy, according to results of an international trial. The findings, if backed by larger studies, could have important implications for designing personalized treatments for this very dangerous type of prostate cancer, the researchers say.

The team of scientists including first author Jose Moreno, M.D., clinical associate professor of urology at Jefferson Medical College of Thomas Jefferson University in Philadelphia and the Kimmel Cancer Center at Jefferson looked at circulating tumor cells (CTCs) in 240 men with metastatic prostate cancer that failed hormone-depletion therapy. They compared levels prior to chemotherapy and after two to five weeks of treatment. They found that those men with more than five tumor cells per blood sample had a worse prognosis than those who had fewer cells. One half of the patients with more than five CTCs lived at least 10 months, whereas half of the men with fewer tumor cells lived substantially longer 21 months.

Dr. Moreno presents the trials findings June 4, 2007 at the annual meeting of the American Society of Clinical Oncology in Chicago.

The results of the 65-site trial also showed that those patients who underwent chemotherapy and whose CTC number went down fared better and had a more favorable prognosis. That is, the level of response to chemotherapy was reflected in the CTC level, notes Dr. Moreno. The numbers held up even after up to 20 weeks of treatment. If chemotherapy doesnt reduce the CTC level, its information that enables the physician to change the drug regimen or perhaps stop treatment, he says.

Dr. Moreno notes that the prostate specific antigen has been a powerful biomarker for cancer presence and a useful way to gauge treatment effectiveness for years, though it has some flaws. He thinks that th
'"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
4-Jun-2007


Page: 1 2

Related medicine news :

1. Trial stops after stroke and mortality significantly reduced by blood
2. Trials underway for essential new TB vaccine
3. ENDEAVOR III Trial reports key findings on new-generation stent
4. NIH names Clinical Trial Units for the Microbicide Trials Network
5. Clinical Trials Units selected for newly restructured HIV/AIDS research networks
6. The Public Library of Science launches the new open access journal PLoS Clinical Trials
7. Trial shows vaccine against cervical cancer provides long-term protection
8. Trial shows malaria vaccine could protect young children from disease for 18 months
9. Trial demonstrates new drugs effectiveness against psoriasis
10. Trial at Jefferson shows new drug may help cancer patients who need stem cell transplants
11. Second implant of US Pilot Trial achieved

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... ... IRF Executive Committee and the IRF Board of Trustees. Representing all segments of ... foundation in meeting its mission of conducting research and providing education highlighting the ...
(Date:1/23/2020)... ... January 23, 2020 , ... NowRx , the ... Orange County today with the grand opening of its state-of-the-art, 4,500 square foot, ... time of a traditional pharmacy. NowRx uses an eco-friendly fleet of delivery ...
(Date:1/22/2020)... (PRWEB) , ... January 22, ... ... that provides hearing, speech, and education services, recently appointed Ilana Glazer as ... communications, and outreach initiatives. Specifically, Ilana directs donor relations, grants administration, external ...
(Date:1/22/2020)... ... January 22, 2020 , ... Dr. Mario ... band can be for reducing food intake, enabling sustainable weight loss and improving ... while bariatric surgery may be a great tool for achieving significant weight loss, ...
(Date:1/12/2020)... ... January 11, 2020 , ... The co-founder and CEO of ... with the annual JP Morgan Healthcare Conference. On Sunday, January 12, Sujuan Ba, ... technology company investors and advisers at the San Francisco office of international law ...
Breaking Medicine News(10 mins):
(Date:1/24/2020)... ... January 24, 2020 , ... The American College of ... a systematic reform of the health care system. Recently, practicing internist and President of ... of Governmental Affairs and Public Policy at ACP, teamed with YourUpdateTV to discuss how ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... assisted living community, has received a deficiency-free survey in 2019 as administered ... receive a deficiency-free survey from the State,” said Glen Cummins Regional Director of ...
(Date:1/23/2020)... ... January 23, 2020 , ... As Sarasota’s older population surges, ... want to stay in their own homes, according to The American Association of Retired ... care . Now, affluent seniors seeking truly professional caregivers have a new option -- ...
Breaking Medicine Technology:
Cached News: